Skip to main content
LobbyMap

Pharmaceutical Research & Manufacturers of America

Pharmaceutical & Health Products · Registrant & Client

B
Influence Score
78/100
High Influence
$141.9M
Total Lobby Spend
8
Policy Issues
56
Lobbyists
26
Revolving Door

Pharmaceutical Research & Manufacturers of America reported $141.9 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 8 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.

Annual Lobbying Spend

Policy Issues

Health IssuesPharmacyMedical/Disease ResearchMedicare/MedicaidCopyright/Patent/TrademarkTradeTaxationBudget/Appropriations

Government Entities Contacted

Dept of Interior
US Senate
Food & Drug Administration
Federal Communications Commission
Dept of Treasury
Dept of State
National Science Foundation
Dept of Health & Human Services
US Trade Representative

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarPharmaceutical Research & Manufacturers of America
HCRBUD
2$10.5M
2020 Apr-JunPharmaceutical Research & Manufacturers of America
BUDTRDHCR+2
2$8.7M
2020 Jul-SepPharmaceutical Research & Manufacturers of America
PHATRDTAX+2
1$10.3M
2020 Oct-DecPharmaceutical Research & Manufacturers of America
MMMPHABUD
4$9.9M
2021 Jan-MarPharmaceutical Research & Manufacturers of America
HCRTAXPHA
3$5.2M
2021 Apr-JunPharmaceutical Research & Manufacturers of America
MMM
3$7.5M
2021 Jul-SepPharmaceutical Research & Manufacturers of America
MMMMEDTAX+2
2$6.9M
2021 Oct-DecPharmaceutical Research & Manufacturers of America
HCRMMMPHA+1
3$6.4M